Preview: India's third largest pharmaceutical company, Cipla, is scheduled to deliver its October-December quarterly earnings ...

Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.

Mumbai: Cipla has announced that Rajeev Kumar Sinha, Global Chief Manufacturing Officer and Senior Management Personnel of ...

Cipla's US sales are expected to be adversely impacted by price erosion and supply disruptions for tumor drug Lanreotide, ...

The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

Cipla on Monday (January 20) announced that the United States Food and Drug Administration conducted an inspection of its ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Pharmaceutical giant Cipla announced a remarkable 32% surge in its third-quarter profits, surpassing market expectations. The company's consolidated net profit soared to Rs 1,056 crore ...

Indian pharma major Cipla Ltd along with Meda Pharmaceuticals Inc, a subsidiary of Swedish specialty drug maker Meda AB, has filed a lawsuit against Canadian pharma company Apotex Inc and Apotex ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.